Engel D Suspension is a combination pharmaceutical formulation containing Domperidone (10 mg), Magaldrate (400 mg), and Simethicone (20 mg) per dose, designed to provide symptomatic relief in gastrointestinal disorders. Domperidone, a dopamine D2 receptor antagonist, acts as a prokinetic agent by enhancing gastrointestinal motility and facilitating gastric emptying, thereby alleviating symptoms such as nausea, vomiting, and bloating. Magaldrate, an antacid composed of aluminum and magnesium hydroxides, neutralizes gastric acid, providing rapid relief from hyperacidity, heartburn, and indigestion. Simethicone, an anti-foaming agent, reduces bloating and discomfort by coalescing gas bubbles in the gastrointestinal tract, facilitating their expulsion. Engel D Suspension is indicated for the management of dyspepsia, gastroesophageal reflux disease (GERD), gastritis, and other acid-related gastrointestinal disturbances accompanied by motility disorders and excessive gas formation. The suspension form ensures ease of administration, especially in pediatric and geriatric populations. It is recommended to be taken before meals or as directed by a healthcare professional. Caution is advised in patients with known hypersensitivity to any component, and it should be used under medical supervision in individuals with hepatic or renal impairment. Engel D Suspension offers a multi-mechanistic approach to gastrointestinal symptom management, enhancing patient comfort and quality of life.